Help
Subscribe


GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy

 29 April 2017

Advanced search
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

Physical, mental, and social problems high with Hep C antivirals

The latest issue of the European Journal of Gastroenterology & Hepatology shows high adverse effects with antiviral therapy in patients with Hep C, that worsen their private and professional relationships, and impact on adherence.

News image

fiogf49gjkf04

The Hepatitis C virus can be successfully treated in up to 60% of infected patients.

However, treatment is long and is associated with significant side-effects.

Dr Susan Zickmund investigated difficulties with this treatment as it is an important factor in patient adherence.

The investigative team enrolled patients receiving Hepatitis C treatment in a tertiary referral center in a cross-sectional study.

The team collected demographic data, functional and emotional status, and co-morbidities from patients or from the medical records.

All participants underwent a semistructured interview, which was analyzed by blinded coders.

A total of 65 patients with a mean age of 46 years, of which 39% were women, were enrolled.

80% described moderate to severe problems attributed to treatment
European Journal of Gastroenterology & Hepatology

The team found that 80% described moderate to severe problems attributed to treatment.

There was a predominance of physical difficulties, including fatigue in 74% of cases, and flu-like symptoms in 32%.

The investigators observed that 38% of patients experienced depression during treatment.

In 31% of cases, physical or emotional problems forced patients to quit their jobs or reduce employment.

The team noted that a fifth of patients attributed deteriorating relationships with friends and family to adverse treatment effects.

Necessary lifestyle adjustments, such as alcohol abstinence, caused frictions with friends in 22% of the participants.

Dr Zickmund's team concluded, “Our findings show a high prevalence of significant adverse effects in patients undergoing antiviral therapy.”

“Whereas the nature and severity of these adverse reactions is consistent with earlier reports, we identified implications with worsening private and professional relationships.”

“To encourage appropriate levels of adherence, healthcare providers should seek information about these indirect treatment effects as they monitor their patients on therapy.”

Eur J Gastroenterol & Hepatol 2006: 18(4): 381
23 March 2006

Go to top of page Email this page Email this page to a colleague

 28 April 2017 
Anastomotic leak in colorectal cancer
 28 April 2017 
Yoga for ulcerative colitis
 28 April 2017 
Risk of pain after liver transarterial chemoembolization
 27 April 2017 
Precision oncology in liver cancer
 27 April 2017 
Celiac disease in adolescents with susceptibility genotypes
 27 April 2017 
Esophageal endocscopic submucosal dissection
 26 April 2017 
Time to colonoscopy and colorectal cancer
 26 April 2017 
National gastric cancer screening program
 26 April 2017 
Iron formulations for anemia in IBD
 25 April 2017 
Asymptomatic carriers and C. diff
 25 April 2017 
Telemedicine tool for IBD
 25 April 2017 
Biologics for mucosal healing in IBD
 24 April 2017 
Poor oral health and IBD
 24 April 2017 
Bacterial infections in cirrhosis 
 24 April 2017 
Functional dyspepsia and duodenal eosinophilia
 21 April 2017 
Treatment of abdominal pain in IBS 
 21 April 2017 
Improving adenoma detection rate
 21 April 2017 
Infection after living donor liver transplantation
 20 April 2017 
Diagnosis of small colorectal polyps
 20 April 2017 
Diagnosis of GERD
 20 April 2017 
Prediction of HCV vertical transmission
 19 April 2017 
Iron replacement therapy in IBD
 19 April 2017 
Heat stroke leading to acute liver failure
 19 April 2017 
Pregnancy and anti-TNF agents in IBD
 14 April 2017 
Water exchange and adenoma detection rate
 14 April 2017 
Survival in IBD associated colorectal cancer
 14 April 2017 
Tacrolimus for liver transplantation
 14 April 2017 
GastroHep.com Easter break
 13 April 2017 
Hepatic manifestations of IBD
 13 April 2017 
Multidisciplinary approach to pancreas cancer
 13 April 2017 
Predicting post-operative Crohn's recurrence
 12 April 2017 
Liver disease in patients for liver transplant
 12 April 2017 
Management of common bile duct stones
 12 April 2017 
Nucleotide analogues for Hep B and cancer risk
 11 April 2017 
Interferon-free regimens for HCV-related Child C cirrhosis
 11 April 2017 
Biodgradable stents and benign intestinal strictures
 11 April 2017 
Weight loss after nutrition training
 10 April 2017 
Polymorphisms associated with liver injury from statins
 10 April 2017 
Genetic risk factors in IBD infections
 10 April 2017 
Regimens for HCV-related Child C cirrhosis
 07 April 2017 
Transition readiness scores in adolescents with IBD
 07 April 2017 
IBD disability index
 07 April 2017 
Hepatocellular carcinoma risk in different etiologies of cirrhosis
 06 April 2017 
Antidepressants in IBD
 06 April 2017 
Meal fat content and reflux
 06 April 2017 
Hep C treatment transformation with direct antiviral agents
 05 April 2017 
Threatening life experiences in ulcerative colitis
 05 April 2017 
Prednisolone and mortality in alcoholic hepatitis 
 05 April 2017 
5-aminosalicylates and colorectal cancer in IBD
 04 April 2017 
Celiac disease in the elderly
 04 April 2017 
IBS after infectious enteritis
 04 April 2017 
Diarrhea after allogeneic stem cell transplantation
 03 April 2017 
Minorities at increased gastric cancer risk
 03 April 2017 
Incidence and risk factors of IBD
 03 April 2017 
Western diet and diverticulitis
 31 March 2017 
GI safety of direct oral anticoagulants
 31 March 2017 
Screening for celiac disease
 31 March 2017 
Low-FODMAP diet in patients with functional GI disorders
 30 March 2017 
Low-grade esophageal dysplasia and cancer risk
 30 March 2017 
Poor oral health and IBD

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us